Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
11 Janeiro 2010 - 1:37PM
PR Newswire (US)
LAKE FOREST, Ill., Jan. 11 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP), a leading global specialty pharmaceutical and
medication delivery company, today announced that the company will
present at the J.P. Morgan 28th Annual Healthcare Conference on
Wednesday, Jan. 13, 2010, in San Francisco. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO ) The
presentation is scheduled to begin at 9:30 a.m. Pacific time on
Wednesday, Jan. 13, 2010, and will be followed by a separate
Q&A session at 10:00 a.m. Pacific time. Both the presentation
and Q&A sessions will be available to all interested parties
through live audiocasts accessible via the investor relations
section of Hospira's Web site at http://www.hospirainvestor.com/.
Listeners should log on approximately 10 minutes in advance to
ensure proper setup to receive the audiocast. The slides
accompanying the presentation will be available on the Hospira Web
site. Replays of both the presentation and Q&A webcasts will be
available on the Hospira Web site approximately 24 hours after the
live presentations for 30 days after the event. About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication
delivery company dedicated to Advancing Wellness(TM). As the world
leader in specialty generic injectable pharmaceuticals, Hospira
offers one of the broadest portfolios of generic acute-care and
oncology injectables, as well as integrated infusion therapy and
medication management solutions. Through its products, Hospira
helps improve the safety, cost and productivity of patient care.
The company is headquartered in Lake Forest, Ill., and has
approximately 14,000 employees. Learn more at
http://www.hospira.com/.
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media: Stacey Eisen, +1-224-212-2276, Financial Community: Karen
King, +1-224-212-2711, both of Hospira, Inc. Web Site:
http://www.hospira.com/
Copyright